Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism

Autores
Abruzzese, Giselle Adriana; Heber, María Florencia; Ferreira, Silvana Rocío; Velez, Leandro Martin; Reynoso, Roxana María; Pignataro, Omar Pedro; Motta, Alicia Beatriz
Año de publicación
2016
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Prenatal hyperandrogenism is hypothesized as one of the main factors contributing to26 the development of polycystic ovary syndrome (PCOS). PCOS patients have high risk27 of developing fatty liver and steatosis. This study aimed to evaluate the role of prenatal28 hyperandrogenism in liver lipid metabolism and fatty liver development. Pregnant rats29 were hyperandrogenized with testosterone. At pubertal age, the prenatally30 hyperandrogenized (PH) female offspring displayed both ovulatory (PHov) and31 anovulatory (PHanov) phenotypes that mimic human PCOS features. We evaluated32 hepatic transferases, liver lipid content, the balance between lipogenesis and fatty acid33 oxidation pathway, oxidant/antioxidant balance and pro-inflammatory status. We also34 evaluated the general metabolic status through growth rate curve, basal glucose and35 insulin levels, glucose tolerance test, HOMA-IR index and serum lipid profile.36 Although neither PH group showed signs of liver lipid content, the lipogenesis and fatty37 oxidation pathways were altered. The PH groups also showed impaired38 oxidant/antioxidant balance, a decrease in the pro-inflammatory pathway (measured by39 prostaglandin E2 and cyclooxygenase-2 levels), decreased glucose tolerance, imbalance40 of circulating lipids and increased risk of metabolic syndrome. We conclude that41 prenatal hyperandrogenism generates both PHov and PHanov phenotypes with signs of42 liver alterations, imbalance in lipid metabolism and increased risk of developing43 metabolic syndrome. The anovulatory phenotype showed more alterations in liver44 lipogenesis and a more impaired balance of insulin and glucose metabolism, being more45 susceptible to the development of steatosis.
Fil: Abruzzese, Giselle Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Heber, María Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Ferreira, Silvana Rocío. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Velez, Leandro Martin. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Reynoso, Roxana María. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Ciencias Fisiológicas. Laboratorio de Endocrinología; Argentina
Fil: Pignataro, Omar Pedro. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Motta, Alicia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Materia
Hyperandrogenism
Lipid Metabolism
Polycystic Ovary Syndrome
Lipids
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/24303
Acceder
id CONICETDig_0c25df99b68158c86fc4cfa1b05d5da2
oai_identifier_str oai:ri.conicet.gov.ar:11336/24303
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Prenatal hyperandrogenism induces alterations that affect liver lipid metabolismAbruzzese, Giselle AdrianaHeber, María FlorenciaFerreira, Silvana RocíoVelez, Leandro MartinReynoso, Roxana MaríaPignataro, Omar PedroMotta, Alicia BeatrizHyperandrogenismLipid MetabolismPolycystic Ovary SyndromeLipidshttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Prenatal hyperandrogenism is hypothesized as one of the main factors contributing to26 the development of polycystic ovary syndrome (PCOS). PCOS patients have high risk27 of developing fatty liver and steatosis. This study aimed to evaluate the role of prenatal28 hyperandrogenism in liver lipid metabolism and fatty liver development. Pregnant rats29 were hyperandrogenized with testosterone. At pubertal age, the prenatally30 hyperandrogenized (PH) female offspring displayed both ovulatory (PHov) and31 anovulatory (PHanov) phenotypes that mimic human PCOS features. We evaluated32 hepatic transferases, liver lipid content, the balance between lipogenesis and fatty acid33 oxidation pathway, oxidant/antioxidant balance and pro-inflammatory status. We also34 evaluated the general metabolic status through growth rate curve, basal glucose and35 insulin levels, glucose tolerance test, HOMA-IR index and serum lipid profile.36 Although neither PH group showed signs of liver lipid content, the lipogenesis and fatty37 oxidation pathways were altered. The PH groups also showed impaired38 oxidant/antioxidant balance, a decrease in the pro-inflammatory pathway (measured by39 prostaglandin E2 and cyclooxygenase-2 levels), decreased glucose tolerance, imbalance40 of circulating lipids and increased risk of metabolic syndrome. We conclude that41 prenatal hyperandrogenism generates both PHov and PHanov phenotypes with signs of42 liver alterations, imbalance in lipid metabolism and increased risk of developing43 metabolic syndrome. The anovulatory phenotype showed more alterations in liver44 lipogenesis and a more impaired balance of insulin and glucose metabolism, being more45 susceptible to the development of steatosis.Fil: Abruzzese, Giselle Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; ArgentinaFil: Heber, María Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; ArgentinaFil: Ferreira, Silvana Rocío. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; ArgentinaFil: Velez, Leandro Martin. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; ArgentinaFil: Reynoso, Roxana María. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Ciencias Fisiológicas. Laboratorio de Endocrinología; ArgentinaFil: Pignataro, Omar Pedro. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Motta, Alicia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; ArgentinaSociety for Endocrinology2016-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/24303Abruzzese, Giselle Adriana; Heber, María Florencia; Ferreira, Silvana Rocío; Velez, Leandro Martin; Reynoso, Roxana María; et al.; Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism; Society for Endocrinology; Journal of Endocrinology; 230; 1-7-2016; 67-790022-07951479-6805CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://joe.endocrinology-journals.org/content/230/1/67.longinfo:eu-repo/semantics/altIdentifier/doi/ 10.1530/JOE-15-0471info:eu-repo/semantics/altIdentifier/pmid/27179108info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:45:15Zoai:ri.conicet.gov.ar:11336/24303instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:45:16.266CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism
title Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism
spellingShingle Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism
Abruzzese, Giselle Adriana
Hyperandrogenism
Lipid Metabolism
Polycystic Ovary Syndrome
Lipids
title_short Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism
title_full Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism
title_fullStr Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism
title_full_unstemmed Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism
title_sort Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism
dc.creator.none.fl_str_mv Abruzzese, Giselle Adriana
Heber, María Florencia
Ferreira, Silvana Rocío
Velez, Leandro Martin
Reynoso, Roxana María
Pignataro, Omar Pedro
Motta, Alicia Beatriz
author Abruzzese, Giselle Adriana
author_facet Abruzzese, Giselle Adriana
Heber, María Florencia
Ferreira, Silvana Rocío
Velez, Leandro Martin
Reynoso, Roxana María
Pignataro, Omar Pedro
Motta, Alicia Beatriz
author_role author
author2 Heber, María Florencia
Ferreira, Silvana Rocío
Velez, Leandro Martin
Reynoso, Roxana María
Pignataro, Omar Pedro
Motta, Alicia Beatriz
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv Hyperandrogenism
Lipid Metabolism
Polycystic Ovary Syndrome
Lipids
topic Hyperandrogenism
Lipid Metabolism
Polycystic Ovary Syndrome
Lipids
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Prenatal hyperandrogenism is hypothesized as one of the main factors contributing to26 the development of polycystic ovary syndrome (PCOS). PCOS patients have high risk27 of developing fatty liver and steatosis. This study aimed to evaluate the role of prenatal28 hyperandrogenism in liver lipid metabolism and fatty liver development. Pregnant rats29 were hyperandrogenized with testosterone. At pubertal age, the prenatally30 hyperandrogenized (PH) female offspring displayed both ovulatory (PHov) and31 anovulatory (PHanov) phenotypes that mimic human PCOS features. We evaluated32 hepatic transferases, liver lipid content, the balance between lipogenesis and fatty acid33 oxidation pathway, oxidant/antioxidant balance and pro-inflammatory status. We also34 evaluated the general metabolic status through growth rate curve, basal glucose and35 insulin levels, glucose tolerance test, HOMA-IR index and serum lipid profile.36 Although neither PH group showed signs of liver lipid content, the lipogenesis and fatty37 oxidation pathways were altered. The PH groups also showed impaired38 oxidant/antioxidant balance, a decrease in the pro-inflammatory pathway (measured by39 prostaglandin E2 and cyclooxygenase-2 levels), decreased glucose tolerance, imbalance40 of circulating lipids and increased risk of metabolic syndrome. We conclude that41 prenatal hyperandrogenism generates both PHov and PHanov phenotypes with signs of42 liver alterations, imbalance in lipid metabolism and increased risk of developing43 metabolic syndrome. The anovulatory phenotype showed more alterations in liver44 lipogenesis and a more impaired balance of insulin and glucose metabolism, being more45 susceptible to the development of steatosis.
Fil: Abruzzese, Giselle Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Heber, María Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Ferreira, Silvana Rocío. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Velez, Leandro Martin. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Reynoso, Roxana María. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Ciencias Fisiológicas. Laboratorio de Endocrinología; Argentina
Fil: Pignataro, Omar Pedro. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Motta, Alicia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
description Prenatal hyperandrogenism is hypothesized as one of the main factors contributing to26 the development of polycystic ovary syndrome (PCOS). PCOS patients have high risk27 of developing fatty liver and steatosis. This study aimed to evaluate the role of prenatal28 hyperandrogenism in liver lipid metabolism and fatty liver development. Pregnant rats29 were hyperandrogenized with testosterone. At pubertal age, the prenatally30 hyperandrogenized (PH) female offspring displayed both ovulatory (PHov) and31 anovulatory (PHanov) phenotypes that mimic human PCOS features. We evaluated32 hepatic transferases, liver lipid content, the balance between lipogenesis and fatty acid33 oxidation pathway, oxidant/antioxidant balance and pro-inflammatory status. We also34 evaluated the general metabolic status through growth rate curve, basal glucose and35 insulin levels, glucose tolerance test, HOMA-IR index and serum lipid profile.36 Although neither PH group showed signs of liver lipid content, the lipogenesis and fatty37 oxidation pathways were altered. The PH groups also showed impaired38 oxidant/antioxidant balance, a decrease in the pro-inflammatory pathway (measured by39 prostaglandin E2 and cyclooxygenase-2 levels), decreased glucose tolerance, imbalance40 of circulating lipids and increased risk of metabolic syndrome. We conclude that41 prenatal hyperandrogenism generates both PHov and PHanov phenotypes with signs of42 liver alterations, imbalance in lipid metabolism and increased risk of developing43 metabolic syndrome. The anovulatory phenotype showed more alterations in liver44 lipogenesis and a more impaired balance of insulin and glucose metabolism, being more45 susceptible to the development of steatosis.
publishDate 2016
dc.date.none.fl_str_mv 2016-07-01
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/24303
Abruzzese, Giselle Adriana; Heber, María Florencia; Ferreira, Silvana Rocío; Velez, Leandro Martin; Reynoso, Roxana María; et al.; Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism; Society for Endocrinology; Journal of Endocrinology; 230; 1-7-2016; 67-79
0022-0795
1479-6805
CONICET Digital
CONICET
url http://hdl.handle.net/11336/24303
identifier_str_mv Abruzzese, Giselle Adriana; Heber, María Florencia; Ferreira, Silvana Rocío; Velez, Leandro Martin; Reynoso, Roxana María; et al.; Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism; Society for Endocrinology; Journal of Endocrinology; 230; 1-7-2016; 67-79
0022-0795
1479-6805
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://joe.endocrinology-journals.org/content/230/1/67.long
info:eu-repo/semantics/altIdentifier/doi/ 10.1530/JOE-15-0471
info:eu-repo/semantics/altIdentifier/pmid/27179108
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Society for Endocrinology
publisher.none.fl_str_mv Society for Endocrinology
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268718604746752
score 13.13397

Publicaciones similares